Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing

被引:45
作者
Brembilla-Perrot, B [1 ]
Suty-Selton, C [1 ]
Beurrier, D [1 ]
Houriez, P [1 ]
Nippert, M [1 ]
de la Chaise, AT [1 ]
Louis, P [1 ]
Claudon, O [1 ]
Andronache, M [1 ]
Abdelaah, A [1 ]
Sadoul, N [1 ]
Juillière, Y [1 ]
机构
[1] CHU Brabois, Dept Cardiol, F-54500 Vandoeuvre Les Nancy, France
关键词
D O I
10.1016/j.jacc.2004.03.075
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVES This study evaluated the causes of syncope and the significance and differences in left ventricular (LV) dysfunction, coronary disease, and idiopathic dilated cardiomyopathy (DCM). BACKGROUND Risk stratification of and indications for an automated defibrillator could differ according to the cause of LV dysfunction. METHODS Electrophysiologic study, including atrial and ventricular programmed stimulation, was performed in 119 patients with coronary disease (group I) and 61 patients with DCM (group II) with an left ventricular ejection fraction (LVEF) <40% and syncope. Patients were followed from one to six years (mean 4 +/- 2 years). RESULTS Sustained monomorphic ventricular tachycardia (VT) was induced in 44 group I patients (37%) and 13 group II patients (21%); ventricular, flutter (>270 beats/min) or ventricular fibrillation (V-F) was induced in 24 group I patients (19%) and 9 group II patients (15%); and various other arrhythimas were identified. Syncope remained unexplained in 34 group I patients (30%) and 16 group II patients (27%). Prognosis depended on the heart disease: VT or VF induction was a predictive factor of mortality in coronary disease and identified a group with high cardiac mortality (46%), compared with patients with a negative study, who had a lower mortality (6%; p < 0.001) than in other studies. Cardiac mortality was only correlated with LVEF in DCM. CONCLUSIONS Various causes could explain syncope in 70% of patients with coronary disease and DCM, but differences were noted: VT was frequent in coronary disease with a bad prognosis, and ischemia could explain syncope; in DCM, different causes such as atrial tachycardia could be responsible for syncope, but the prognosis only depended on LVEF. (C) 2004 by the American College of Cardiology Foundation.
引用
收藏
页码:594 / 601
页数:8
相关论文
共 30 条
[1]
Diagnostic value of history in patients with syncope with or without heart disease [J].
Alboni, P ;
Brignole, M ;
Menozzi, C ;
Raviele, A ;
Del Rosso, A ;
Dinelli, M ;
Solano, A ;
Bottoni, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) :1921-1928
[2]
Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias - A comparison with patients known to have sustained ventricular tachycardia [J].
Andrews, NP ;
Fogel, RI ;
Pelargonio, G ;
Evans, JJ ;
Prystowsky, EN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (07) :2023-2030
[3]
DOES THE INDUCTION OF VENTRICULAR FLUTTER OR FIBRILLATION AT ELECTROPHYSIOLOGIC TESTING AFTER MYOCARDIAL-INFARCTION HAVE ANY PROGNOSTIC-SIGNIFICANCE [J].
BOURKE, JP ;
RICHARDS, DAB ;
ROSS, DL ;
MCGUIRE, MA ;
UTHER, JB .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (07) :431-435
[4]
Significance and prevalence of inducible atrial tachyarrhythmias in patients undergoing electrophysiologic study for presyncope or syncope [J].
BrembillaPerrot, B ;
Beurrier, D ;
delaChaise, AT ;
SutySelton, C ;
Jacquemin, L ;
Thiel, B ;
Louis, P .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 53 (01) :61-69
[5]
DIAGNOSTIC-VALUE OF VENTRICULAR STIMULATION IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY [J].
BREMBILLAPERROT, B ;
DONETTI, J ;
DELACHAISE, AT ;
SADOUL, N ;
ALIOT, E ;
JUILLIERE, Y .
AMERICAN HEART JOURNAL, 1991, 121 (04) :1124-1131
[6]
PROGRAMMED VENTRICULAR STIMULATION IN SURVIVORS OF ACUTE MYOCARDIAL-INFARCTION - LONG-TERM FOLLOW-UP [J].
BREMBILLAPERROT, B ;
DELACHAISE, AT ;
BRIANCON, S ;
SUTYSELTON, C ;
BEURRIER, D ;
MARTIN, N ;
THIEL, B ;
LOUIS, P ;
DANCHIN, N .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 49 (01) :55-65
[7]
Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope [J].
Brilakis, ES ;
Shen, WK ;
Hammill, SC ;
Hodge, DO ;
Rea, RF ;
Lexvold, NY ;
Friedman, PA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2001, 24 (11) :1623-1630
[8]
Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease - An analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial [J].
Buxton, AE ;
Lee, KL ;
Hafley, GE ;
Wyse, DG ;
Fisher, JD ;
Lehmann, MH ;
Pires, LA ;
Gold, MR ;
Packer, DL ;
Josephson, ME ;
Prystowsky, EN ;
Talajic, MR .
CIRCULATION, 2002, 106 (19) :2466-2472
[9]
Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian Implantable Defibrillator Study implantable cardioverter defibrillatory efficacy score in the Antiarrhythmics Versus Implantable Defibrillators Trial [J].
Exner, DV ;
Sheldon, RS ;
Pinski, SL ;
Kron, J ;
Hallstrom, A .
AMERICAN HEART JOURNAL, 2001, 141 (01) :99-104
[10]
Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia [J].
Grimm, W ;
Hoffmann, J ;
Menz, V ;
Luck, K ;
Maisch, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :739-745